New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 9, 2014
09:25 EDTELGX, ELGX, ELGX, ARTC, ARTC, ARTC, BAXS, BAXS, BAXS, NVDQ, NVDQ, NVDQ, OXFD, OXFD, OXFD, FLDM, FLDM, FLDM, Q, Q, Q, ATRC, ATRC, ATRCPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.
News For ELGX;ARTC;BAXS;NVDQ;OXFD;FLDM;Q;ATRC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
11:34 EDTFLDMLeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
October 20, 2014
07:10 EDTFLDMAmerican Society of Human Genetics to hold annual meeting
Subscribe for More Information
October 14, 2014
06:06 EDTELGXDeerfield reports 6.7% passive stake in Endologix
October 10, 2014
10:01 EDTQOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:57 EDTQQuintiles upgraded at ISI Group
As previously reported, ISI Group upgraded Quintiles to Buy from Neutral. The firm sees further upside to shares driven by market product development growth, effective capital deployment, and an improving outlook for IHS. Price target is $61.
06:19 EDTQQuintiles upgraded to Buy from Neutral at ISI Group
Subscribe for More Information
October 9, 2014
16:04 EDTATRCAtriCure completes enrollment in post approval study for Synergy Ablation system
AtriCure announced enrollment in the ABLATE Post Approval Study, or PAS, is complete. As of October 3, the ABLATE PAS enrolled 365 patients at 40 hospitals across the U.S. AtriCure expects to release preliminary data from the study in about a year, with a complete report expected to be published in three years.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use